EBR Systems (ASX:EBR) has received the US Centers for Medicare & Medicaid Services' (CMS) Transitional Pass-Through (TPT) reimbursement for the Company's WiSE Cardiac Resynchronisation Therapy System, effective Oct. 1, according to a Monday filing with the Australian bourse.
The reimbursement will be provided for three years, the filing said.
Shares of the company rose 2% in recent Monday trade.